『Beta Finch - S&P 100 - EN』のカバーアート

Beta Finch - S&P 100 - EN

Beta Finch - S&P 100 - EN

著者： Beta Finch
無料で聴く

Top 100 US-listed companies by market capitalization. AI-powered earnings call analysis for S&P 100 (SP100). Two AI hosts break down quarterly results, key metrics, and market implications in digestible podcast episodes.2026 Beta Finch 個人ファイナンス 経済学
エピソード
  • Medtronic Q4 2026 Earnings Analysis

    Medtronic Q4 2026 Earnings Analysis
    2026/06/04
    More earnings analysis: https://betafinch.com
    Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
    ──────────
    # Beta Finch Podcast Script: Medtronic Q4 2026 Earnings

    **ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're unpacking Medtronic's fourth quarter 2026 results, and folks, this is a company that's clearly hitting its stride.

    Before we dive in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

    **JORDAN:** Thanks Alex, and wow - where do we even start with Medtronic? These numbers are impressive. The company just posted $9.8 billion in Q4 revenue, up nearly 10% reported and 6.6% organically. But here's what really caught my attention - this caps off their strongest annual performance in a decade.

    **ALEX:** That's right, Jordan. For the full fiscal year, they hit $36.4 billion in revenue with 8.4% reported growth and 5.8% organic growth. CEO Geoff Martha was clearly proud of these results, calling it a reflection of their "commitment to operational rigor" while investing in durable growth. But let's talk about what's really driving this performance.

    **JORDAN:** The star of the show has got to be their Cardiac Ablation Solutions business - or CAS. This division delivered 78% worldwide growth and gained 8 points of U.S. market share. Their PFA technology saw 145% global growth, with their Sphere-9 catheter continuing to show "broad versatility," as Martha put it.

    **ALEX:** And here's what's really exciting about CAS - they're still in the "early innings," as CFO Thierry Pieton noted. The company increased their installed base by 40% just in the fourth quarter alone. They're now annualizing over $2 billion in revenue and are on track to hit that $2 billion trailing mark in the first quarter of fiscal 2027. That's massive scale in a high-growth market.

    **JORDAN:** What I found fascinating was Martha's comment about "completely surrounding the electrophysiology space." They're not just selling one product - they're building an entire ecosystem. They launched Sphere-9 in Japan, got FDA approval for a U.S. VT pivotal trial, and even announced two targeted investments in ICE catheter technology this morning.

    **ALEX:** Speaking of investments, let's talk about their capital allocation strategy because this is where you really see the company's long-term vision. In Q4 alone, they closed or announced nearly $2 billion in additional investments through M&A and venture deals. They acquired CathWorks for their AI-powered FFRangio system, announced plans to buy Scientia for neurovascular guidewire tech, and made investments in everything from chronic pain management to pulmonary artery denervation.

    **JORDAN:** That's a great point, Alex. And it's not just about buying technology - it's about strategic positioning. Take their Symplicity Spyral system for treating hypertension. This business is now annualizing at $100 million, and they've doubled their weekly procedure volumes since getting the NCD coverage decision. Martha emphasized that 18 million Americans still have uncontrolled hypertension despite multiple medications - that's a massive addressable market.

    **ALEX:** Let's shift to the numbers that investors will be watching closely. For fiscal 2027, Medtronic is guiding to organic revenue growth of 6.75% to 7.25%. Now, there's an extra selling week baked into that, which adds about 125 basis points, but even adjusting for that, we're looking at solid mid-single-digit growth acceleration.

    **JORDAN:** The guidance is particularly interesting because of how they're handling the MiniMed diabetes business. They completed the IPO in March, but

    This episode includes AI-generated content.
    続きを読む 一部表示
    9 分
  • Broadcom Q2 2026 Earnings Analysis

    Broadcom Q2 2026 Earnings Analysis
    2026/06/04
    More earnings analysis: https://betafinch.com
    Groups: CHIPS (https://betafinch.com/groups/CHIPS), AI_LEADERS (https://betafinch.com/groups/AI_LEADERS)
    ──────────
    # Beta Finch Podcast Script: Broadcom Q2 2026 Earnings

    **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that matter. I'm Alex, and joining me as always is Jordan. Today we're diving into Broadcom's absolutely explosive Q2 2026 results that had Wall Street buzzing. But before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

    **JORDAN**: Thanks Alex, and wow - where do we even begin with these numbers? Broadcom just delivered what might be one of the most impressive quarters we've seen in the semiconductor space. We're talking about $22.2 billion in total revenue, up 48% year-over-year, with AI semiconductor revenue alone hitting $10.8 billion.

    **ALEX**: That AI number is just staggering, Jordan. To put it in perspective, their AI semiconductor business grew 143% year-over-year. But what really caught my attention was CEO Hock Tan's guidance - they're expecting AI semiconductor revenue to hit $16 billion in Q3, which would be over 200% growth year-over-year.

    **JORDAN**: And let's talk about those margins, because this is where Broadcom really shows its operational excellence. Operating margin hit a record 67% with adjusted EBITDA at 69% of revenue. Even as they're scaling up massively, they're maintaining these incredible margins through operational leverage.

    **ALEX**: The bookings number was absolutely wild too - $30 billion in AI semiconductor bookings against $10.8 billion they actually shipped. That's nearly 3x coverage, which tells us demand is just insatiable right now.

    **JORDAN**: Speaking of demand, let's break down what's driving this growth. Broadcom has essentially become the go-to partner for the biggest names in AI. They've got long-term agreements with Google for multiple generations of TPUs and AI networking. They're providing Anthropic with access to over 1 gigawatt of compute this year, with plans to scale that to 5 gigawatts starting in 2027.

    **ALEX**: And the OpenAI partnership is massive - they're on track for production late this year with a commitment to deploy 1.3 gigawatts in 2027 as part of a larger 10-gigawatt agreement through 2029. Then there's Meta with their MTIA partnership expecting to deploy 3 gigawatts through the end of 2028.

    **JORDAN**: What I found fascinating in the Q&A was when Tan talked about their strategic vision. They're not just selling chips anymore - they're creating what they call the "AI XPU platform" with Apollo, Blackstone, and other major investors to deploy over 20 gigawatts of compute capacity. The first tranche alone is valued at $35 billion.

    **ALEX**: That's a brilliant move, Jordan. Instead of just hoping their customers can finance these massive deployments, Broadcom is essentially helping create the infrastructure to fund it. It's like they're not just building the highway, they're helping finance the construction too.

    **JORDAN**: And let's not forget about networking - this was about 40% of their AI revenue in the quarter. Tan mentioned they have at least one generation of technology leadership in networking, which is crucial because you can't build scalable AI clusters without world-class networking. They're shipping the industry's only 100 terabit Ethernet switch and are already taping out a 200 terabit version.

    **ALEX**: The guidance going forward is just jaw-dropping. For fiscal 2026, they're expecting AI semiconductor revenue of $56 billion - that's up approximately 180% from fiscal 2025. And they're reiterating that fiscal 2027 will exceed $100 billion in AI semiconductor revenue.

    **JORDAN**: One thing that

    This episode includes AI-generated content.
    続きを読む 一部表示
    8 分
  • Boeing Q1 2026 Earnings Analysis

    Boeing Q1 2026 Earnings Analysis
    2026/06/02
    More earnings analysis: https://betafinch.com
    Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS)
    ──────────
    # Beta Finch Podcast Script: Boeing Q1 2026 Earnings

    **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the quarterly results that are moving markets. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're unpacking Boeing's first quarter 2026 earnings, and folks, this is a company that's been through quite a journey over the past few years.

    Before we get started, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

    **JORDAN:** Thanks Alex. And what a quarter this was for Boeing. We're seeing some real signs of stability and momentum building across their business segments. The headline numbers tell a compelling story - revenue jumped 14% to $22.2 billion, which is solid growth across all three of their main divisions.

    **ALEX:** That's right, and while they're still posting a core loss of 20 cents per share, that's actually an improvement from last year. What really caught my attention was CEO Kelly Ortberg's tone - he seems genuinely optimistic about where they're headed. He said they're "off to a really good start and headed in the right direction."

    **JORDAN:** Absolutely, and let's talk about what's driving that optimism. The production story is fascinating here. They've stabilized 737 production at 42 aircraft per month, and they're planning to ramp up to 47 per month this summer. But here's what's really interesting - they delivered the final 737 MAX from their "shadow factory" inventory in Q1. That's significant because it means they're finally clearing out the backlog of aircraft built during the production halt.

    **ALEX:** That's huge, Jordan. And speaking of production, they're bringing online a fourth 737 production line - the "North Line" in Everett. This is part of their plan to eventually reach 52 aircraft per month. What struck me was how methodical they're being about this ramp-up. They're moving experienced workers from their stable Renton facility to train new employees at Everett.

    **JORDAN:** Smart approach, especially given their quality focus. They mentioned a 20% reduction in final assembly rework hours compared to last year - that's the kind of operational improvement that builds confidence. But let's address the elephant in the room - the Middle East conflict and its potential impact.

    **ALEX:** Right, this came up several times during the Q&A. Ortberg was pretty clear that they haven't seen any delivery deferrals yet, and they actually delivered four aircraft to Middle East customers during the quarter. But he acknowledged they're watching fuel prices closely, since higher jet fuel costs could impact airline operations and aftermarket demand.

    **JORDAN:** What's interesting is how Boeing is positioned if defense spending increases due to the conflict. Ortberg highlighted that their defense platforms - the Apache helicopter, Patriot missile systems, F-15EX fighters - are all seeing increased demand. He mentioned seeing potential upside in their five-year defense outlook compared to what they planned last year.

    **ALEX:** Let's dig into those segment numbers. Commercial Airplanes had revenue of $9.2 billion, up 13%, though they're still posting negative margins. Defense, Space & Security grew 21% to $7.6 billion with a 3.1% operating margin. And Global Services - their most profitable segment - delivered $5.4 billion in revenue with an impressive 18.1% operating margin.

    **JORDAN:** Those Global Services numbers are really solid. They booked $8 billion in new orders with a book-to-bill ratio of 1.6, and their backlog hit a record $33 billion. This is the steady, cash-generating business th

    This episode includes AI-generated content.
    続きを読む 一部表示
    9 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません